1. The role of economic evaluation in vaccine decision making

   • Robert Welte
   • Caroline L. Trotter
   • Philippe Beutels

   Review Article 17 September 2012 Pages: 855 - 874

   

2. Economic implications of biological therapies for Crohn’s disease

   • Keith Bodger

   Review Article 17 September 2012 Pages: 875 - 888

   

3. A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults

   • Emily Beth Devine
   • Zafar Hakim
   • Jesse Green

   Review Article 17 September 2012 Pages: 889 - 912

   

4. Cost-benefit analysis of vaccination against tick-borne encephalitis among French troops

   • Guillaume Desjeux
   • Laurent Galoisy-Guibal
   • Cyrille Colin

   Original Research Article 17 September 2012 Pages: 913 - 926

   

5. Cost effectiveness of dalteparin for preventing venous thromboembolism in abdominal surgery

   • Adrienne Heerey
   • Sanjeev Suri

   Original Research Article 17 September 2012 Pages: 927 - 944

   

6. Linezolid

   • Greg L. Plosker
   • David P. Figgitt

   Adis Drug Evaluation 17 September 2012 Pages: 945 - 964

   

7. The public financing of pharmaceuticals: An economic approach

   • Eric J. Moskowitz
   • David B. Nash

   Book Review 17 September 2012 Pages: 965 - 965